| Regulatory Rapporteur June 2022 | MEMBERS |
| What can past decision-making data tell us about how the FDA will make future combination product categorisation decisions? | MEMBERS |
| Updates to quality legislation from the EMA | MEMBERS |
| Medical device standards update | MEMBERS |
| Evolutions in patient healthcare at the MHRA | MEMBERS |
| 10 years of pharmacovigilance legislation: the perspective of a national agency | MEMBERS |
| Exploring Amgen's Project Orbis Experience with sotorasib | MEMBERS |